NLS CDMO

PolyPeptide Group has announces the planned doubling of solid-phase peptide synthesis (SPPS) capacity at its manufacturing site in Malmö, Sweden.

You are arranging a Nordic tour, beginning at BIO-Europe in Stockholm on November 4-6, for different actors within life science manufacturing to showcase our region’s strengths within the field.

Rokote Laboratories Finland has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2. 3PBIOVIAN will provide Rokote Laboratories with Drug Substance and Drug Product to bring the intranasal FINCoVac 2.1 vaccine into Phase I clinical studies. The […]

The company estimates this will create several hundred more jobs, which they will begin filling this year. The grand opening of the new facility, held on June 18th, hosted elected officials and leaders from the Danish political and life science community, including the Ministry of Taxation, the Japanese Ministry in Denmark, and the Mayor of […]

Curida Holding has announced a significant growth investment from Signet Healthcare Partners, a New York-based healthcare private equity firm together with existing shareholders, Canica, Investinor, Klaveness Marine and Farvatn Private Equity. This investment will enable Curida to accelerate its expansion plans, including enhancing facility capabilities and growing its industry position, it states. The total investment […]

The US-based private equity firm has committed to acquire Recipharm’s sites in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain. The colleagues at those sites form a new organisation under the leadership of Peter Kruger, Group Managing Director, states Recipharm. “The consolidation of our sites network […]